Alprostadil (pfe1 recalls

The FDA has published 3 recalls involving Alprostadil (pfe1 since 2015. The latest was reported on 17 Jun 2015. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2015

Last 12 months0reported

Class I00% of total

Ongoing0latest 17 Jun 2015

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why alprostadil (pfe1 is recalled

Sterility3100%

Companies

Montana Compounding Pharmacy3100%

By year

20153100%

All alprostadil (pfe1 recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
17 Jun 2015Drug	CLASS II	Alprostadil (PFE1), solution, 20 mcg/mL, injectable vial recalled	Montana Compounding Pharmacy	Sterility	MT, ND
17 Jun 2015Drug	CLASS II	Alprostadil (PFE1), Solution, 10 mcg/mL, injectable vial recalled	Montana Compounding Pharmacy	Sterility	MT, ND
17 Jun 2015Drug	CLASS II	Alprostadil (PFE1), solution, 30 mcg/mL, injectable vial recalled	Montana Compounding Pharmacy	Sterility	MT, ND

Should you stop taking Alprostadil (pfe1?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.